nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—coronary artery disease	0.3	1	CbGaD
Zuclopenthixol—CYP2D6—Niacin—coronary artery disease	0.0221	0.173	CbGbCtD
Zuclopenthixol—CYP2D6—Timolol—coronary artery disease	0.0205	0.161	CbGbCtD
Zuclopenthixol—CYP2D6—Captopril—coronary artery disease	0.0181	0.141	CbGbCtD
Zuclopenthixol—CYP2D6—Simvastatin—coronary artery disease	0.0175	0.137	CbGbCtD
Zuclopenthixol—CYP2D6—Lovastatin—coronary artery disease	0.0171	0.134	CbGbCtD
Zuclopenthixol—CYP2D6—Pravastatin—coronary artery disease	0.0171	0.134	CbGbCtD
Zuclopenthixol—CYP2D6—Atorvastatin—coronary artery disease	0.0156	0.122	CbGbCtD
Zuclopenthixol—HTR2A—arteriole—coronary artery disease	0.00423	0.188	CbGeAlD
Zuclopenthixol—HTR2A—pulmonary artery—coronary artery disease	0.00277	0.123	CbGeAlD
Zuclopenthixol—HTR2A—sympathetic nervous system—coronary artery disease	0.0027	0.12	CbGeAlD
Zuclopenthixol—HTR2A—vagus nerve—coronary artery disease	0.00261	0.116	CbGeAlD
Zuclopenthixol—HTR2A—vein—coronary artery disease	0.00252	0.112	CbGeAlD
Zuclopenthixol—HTR2A—autonomic nervous system—coronary artery disease	0.00181	0.0804	CbGeAlD
Zuclopenthixol—HTR2A—artery—coronary artery disease	0.00103	0.0456	CbGeAlD
Zuclopenthixol—HTR2A—endothelium—coronary artery disease	0.000868	0.0385	CbGeAlD
Zuclopenthixol—ADRA1A—heart—coronary artery disease	0.000586	0.026	CbGeAlD
Zuclopenthixol—Loxapine—HRH2—coronary artery disease	0.000582	0.111	CrCbGaD
Zuclopenthixol—ADRA1A—cardiovascular system—coronary artery disease	0.000553	0.0245	CbGeAlD
Zuclopenthixol—ADRA2A—heart—coronary artery disease	0.000445	0.0197	CbGeAlD
Zuclopenthixol—ADRA1A—blood—coronary artery disease	0.000437	0.0194	CbGeAlD
Zuclopenthixol—ADRA2A—cardiac atrium—coronary artery disease	0.000381	0.0169	CbGeAlD
Zuclopenthixol—HTR2A—heart—coronary artery disease	0.000379	0.0168	CbGeAlD
Zuclopenthixol—HTR2A—cardiovascular system—coronary artery disease	0.000357	0.0158	CbGeAlD
Zuclopenthixol—ADRA2A—blood—coronary artery disease	0.000332	0.0147	CbGeAlD
Zuclopenthixol—Flupentixol—HTR2A—coronary artery disease	0.000299	0.0572	CrCbGaD
Zuclopenthixol—HTR2A—blood—coronary artery disease	0.000282	0.0125	CbGeAlD
Zuclopenthixol—CYP2D6—blood—coronary artery disease	0.000257	0.0114	CbGeAlD
Zuclopenthixol—Amoxapine—HTR7—coronary artery disease	0.000254	0.0484	CrCbGaD
Zuclopenthixol—Thioridazine—HTR7—coronary artery disease	0.000215	0.041	CrCbGaD
Zuclopenthixol—Loxapine—HTR7—coronary artery disease	0.000198	0.0378	CrCbGaD
Zuclopenthixol—Perphenazine—HTR7—coronary artery disease	0.000197	0.0377	CrCbGaD
Zuclopenthixol—Quetiapine—HTR7—coronary artery disease	0.000193	0.0369	CrCbGaD
Zuclopenthixol—Pipotiazine—CYP2C19—coronary artery disease	0.000179	0.0342	CrCbGaD
Zuclopenthixol—Loxapine—ADRB1—coronary artery disease	0.00017	0.0324	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2A—coronary artery disease	0.000167	0.032	CrCbGaD
Zuclopenthixol—Clozapine—HTR7—coronary artery disease	0.000166	0.0318	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR7—coronary artery disease	0.000156	0.0299	CrCbGaD
Zuclopenthixol—Trazodone—HTR2A—coronary artery disease	0.000155	0.0296	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR2A—coronary artery disease	0.000147	0.0282	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—coronary artery disease	0.000145	0.0277	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—coronary artery disease	0.000145	0.0277	CrCbGaD
Zuclopenthixol—Thioridazine—CYP2C19—coronary artery disease	0.000133	0.0254	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—coronary artery disease	0.000127	0.0244	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2A—coronary artery disease	0.000125	0.0239	CrCbGaD
Zuclopenthixol—Vomiting—Ezetimibe—coronary artery disease	0.000123	0.000351	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Pravastatin—coronary artery disease	0.000123	0.000351	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Perindopril—coronary artery disease	0.000123	0.000351	CcSEcCtD
Zuclopenthixol—Anxiety—Timolol—coronary artery disease	0.000123	0.000351	CcSEcCtD
Zuclopenthixol—Pruritus—Olmesartan—coronary artery disease	0.000123	0.00035	CcSEcCtD
Zuclopenthixol—Decreased appetite—Losartan—coronary artery disease	0.000123	0.00035	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000122	0.000349	CcSEcCtD
Zuclopenthixol—Abdominal pain—Captopril—coronary artery disease	0.000122	0.000349	CcSEcCtD
Zuclopenthixol—Body temperature increased—Captopril—coronary artery disease	0.000122	0.000349	CcSEcCtD
Zuclopenthixol—Perphenazine—CYP2C19—coronary artery disease	0.000122	0.0234	CrCbGaD
Zuclopenthixol—Dizziness—Simvastatin—coronary artery disease	0.000122	0.000348	CcSEcCtD
Zuclopenthixol—Rash—Ezetimibe—coronary artery disease	0.000122	0.000348	CcSEcCtD
Zuclopenthixol—Dermatitis—Ezetimibe—coronary artery disease	0.000122	0.000348	CcSEcCtD
Zuclopenthixol—Discomfort—Timolol—coronary artery disease	0.000122	0.000348	CcSEcCtD
Zuclopenthixol—Asthenia—Niacin—coronary artery disease	0.000122	0.000347	CcSEcCtD
Zuclopenthixol—Fatigue—Losartan—coronary artery disease	0.000122	0.000347	CcSEcCtD
Zuclopenthixol—Headache—Ezetimibe—coronary artery disease	0.000121	0.000346	CcSEcCtD
Zuclopenthixol—Malaise—Lisinopril—coronary artery disease	0.000121	0.000346	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Ramipril—coronary artery disease	0.000121	0.000345	CcSEcCtD
Zuclopenthixol—Vertigo—Lisinopril—coronary artery disease	0.000121	0.000344	CcSEcCtD
Zuclopenthixol—Dry mouth—Timolol—coronary artery disease	0.000121	0.000344	CcSEcCtD
Zuclopenthixol—Pain—Losartan—coronary artery disease	0.000121	0.000344	CcSEcCtD
Zuclopenthixol—Constipation—Losartan—coronary artery disease	0.000121	0.000344	CcSEcCtD
Zuclopenthixol—Syncope—Lisinopril—coronary artery disease	0.000121	0.000344	CcSEcCtD
Zuclopenthixol—Vomiting—Eplerenone—coronary artery disease	0.00012	0.000344	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Furosemide—coronary artery disease	0.00012	0.000344	CcSEcCtD
Zuclopenthixol—Leukopenia—Lisinopril—coronary artery disease	0.00012	0.000343	CcSEcCtD
Zuclopenthixol—Nausea—Fenofibrate—coronary artery disease	0.00012	0.000343	CcSEcCtD
Zuclopenthixol—Pruritus—Niacin—coronary artery disease	0.00012	0.000342	CcSEcCtD
Zuclopenthixol—Quetiapine—CYP2C19—coronary artery disease	0.00012	0.0229	CrCbGaD
Zuclopenthixol—Asthenia—Pravastatin—coronary artery disease	0.00012	0.000342	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Furosemide—coronary artery disease	0.00012	0.000341	CcSEcCtD
Zuclopenthixol—Rash—Eplerenone—coronary artery disease	0.000119	0.000341	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Trandolapril—coronary artery disease	0.000119	0.000341	CcSEcCtD
Zuclopenthixol—Dermatitis—Eplerenone—coronary artery disease	0.000119	0.000341	CcSEcCtD
Zuclopenthixol—Diarrhoea—Valsartan—coronary artery disease	0.000119	0.00034	CcSEcCtD
Zuclopenthixol—Shock—Ramipril—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Enalapril—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Abdominal pain—Perindopril—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Body temperature increased—Perindopril—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Palpitations—Lisinopril—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Diarrhoea—Olmesartan—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Headache—Eplerenone—coronary artery disease	0.000119	0.000339	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Ramipril—coronary artery disease	0.000119	0.000338	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Ramipril—coronary artery disease	0.000118	0.000338	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Timolol—coronary artery disease	0.000118	0.000337	CcSEcCtD
Zuclopenthixol—Pruritus—Pravastatin—coronary artery disease	0.000118	0.000337	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Lisinopril—coronary artery disease	0.000118	0.000337	CcSEcCtD
Zuclopenthixol—Nausea—Clopidogrel—coronary artery disease	0.000118	0.000337	CcSEcCtD
Zuclopenthixol—Tachycardia—Ramipril—coronary artery disease	0.000118	0.000337	CcSEcCtD
Zuclopenthixol—Skin disorder—Ramipril—coronary artery disease	0.000117	0.000335	CcSEcCtD
Zuclopenthixol—Vomiting—Simvastatin—coronary artery disease	0.000117	0.000335	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Telmisartan—coronary artery disease	0.000117	0.000335	CcSEcCtD
Zuclopenthixol—Nausea—Lovastatin—coronary artery disease	0.000117	0.000334	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Ramipril—coronary artery disease	0.000117	0.000333	CcSEcCtD
Zuclopenthixol—Rash—Simvastatin—coronary artery disease	0.000116	0.000332	CcSEcCtD
Zuclopenthixol—Dermatitis—Simvastatin—coronary artery disease	0.000116	0.000332	CcSEcCtD
Zuclopenthixol—Asthenia—Trandolapril—coronary artery disease	0.000116	0.000332	CcSEcCtD
Zuclopenthixol—Shock—Timolol—coronary artery disease	0.000116	0.000332	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Losartan—coronary artery disease	0.000116	0.000331	CcSEcCtD
Zuclopenthixol—Diarrhoea—Niacin—coronary artery disease	0.000116	0.000331	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Timolol—coronary artery disease	0.000116	0.000331	CcSEcCtD
Zuclopenthixol—Asthenia—Enalapril—coronary artery disease	0.000116	0.00033	CcSEcCtD
Zuclopenthixol—Headache—Simvastatin—coronary artery disease	0.000116	0.00033	CcSEcCtD
Zuclopenthixol—Body temperature increased—Furosemide—coronary artery disease	0.000116	0.00033	CcSEcCtD
Zuclopenthixol—Abdominal pain—Furosemide—coronary artery disease	0.000116	0.00033	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Losartan—coronary artery disease	0.000115	0.000329	CcSEcCtD
Zuclopenthixol—Dizziness—Valsartan—coronary artery disease	0.000115	0.000329	CcSEcCtD
Zuclopenthixol—Anorexia—Ramipril—coronary artery disease	0.000115	0.000329	CcSEcCtD
Zuclopenthixol—Nausea—Ezetimibe—coronary artery disease	0.000115	0.000328	CcSEcCtD
Zuclopenthixol—Skin disorder—Timolol—coronary artery disease	0.000115	0.000328	CcSEcCtD
Zuclopenthixol—Dizziness—Olmesartan—coronary artery disease	0.000115	0.000327	CcSEcCtD
Zuclopenthixol—Pruritus—Trandolapril—coronary artery disease	0.000115	0.000327	CcSEcCtD
Zuclopenthixol—Myalgia—Lisinopril—coronary artery disease	0.000114	0.000326	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Timolol—coronary artery disease	0.000114	0.000326	CcSEcCtD
Zuclopenthixol—Asthenia—Telmisartan—coronary artery disease	0.000114	0.000326	CcSEcCtD
Zuclopenthixol—Pruritus—Enalapril—coronary artery disease	0.000114	0.000326	CcSEcCtD
Zuclopenthixol—Diarrhoea—Pravastatin—coronary artery disease	0.000114	0.000326	CcSEcCtD
Zuclopenthixol—Chlorprothixene—HTR2A—coronary artery disease	0.000114	0.0218	CrCbGaD
Zuclopenthixol—Anxiety—Lisinopril—coronary artery disease	0.000114	0.000325	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000114	0.000324	CcSEcCtD
Zuclopenthixol—Discomfort—Lisinopril—coronary artery disease	0.000113	0.000322	CcSEcCtD
Zuclopenthixol—Hypotension—Ramipril—coronary artery disease	0.000113	0.000322	CcSEcCtD
Zuclopenthixol—Anorexia—Timolol—coronary artery disease	0.000113	0.000321	CcSEcCtD
Zuclopenthixol—Pruritus—Telmisartan—coronary artery disease	0.000113	0.000321	CcSEcCtD
Zuclopenthixol—Nausea—Eplerenone—coronary artery disease	0.000113	0.000321	CcSEcCtD
Zuclopenthixol—Dizziness—Niacin—coronary artery disease	0.000112	0.00032	CcSEcCtD
Zuclopenthixol—Dry mouth—Lisinopril—coronary artery disease	0.000112	0.000319	CcSEcCtD
Zuclopenthixol—Abdominal pain—Losartan—coronary artery disease	0.000111	0.000318	CcSEcCtD
Zuclopenthixol—Body temperature increased—Losartan—coronary artery disease	0.000111	0.000318	CcSEcCtD
Zuclopenthixol—Asthenia—Captopril—coronary artery disease	0.000111	0.000317	CcSEcCtD
Zuclopenthixol—Diarrhoea—Trandolapril—coronary artery disease	0.000111	0.000316	CcSEcCtD
Zuclopenthixol—Vomiting—Valsartan—coronary artery disease	0.000111	0.000316	CcSEcCtD
Zuclopenthixol—Diarrhoea—Enalapril—coronary artery disease	0.00011	0.000315	CcSEcCtD
Zuclopenthixol—Hypotension—Timolol—coronary artery disease	0.00011	0.000315	CcSEcCtD
Zuclopenthixol—Dizziness—Pravastatin—coronary artery disease	0.00011	0.000315	CcSEcCtD
Zuclopenthixol—Vomiting—Olmesartan—coronary artery disease	0.00011	0.000315	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.00011	0.000314	CcSEcCtD
Zuclopenthixol—Rash—Valsartan—coronary artery disease	0.00011	0.000314	CcSEcCtD
Zuclopenthixol—Dermatitis—Valsartan—coronary artery disease	0.00011	0.000313	CcSEcCtD
Zuclopenthixol—Nausea—Simvastatin—coronary artery disease	0.00011	0.000313	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Lisinopril—coronary artery disease	0.00011	0.000313	CcSEcCtD
Zuclopenthixol—Pruritus—Captopril—coronary artery disease	0.00011	0.000313	CcSEcCtD
Zuclopenthixol—Rash—Olmesartan—coronary artery disease	0.000109	0.000312	CcSEcCtD
Zuclopenthixol—Insomnia—Ramipril—coronary artery disease	0.000109	0.000312	CcSEcCtD
Zuclopenthixol—Dermatitis—Olmesartan—coronary artery disease	0.000109	0.000312	CcSEcCtD
Zuclopenthixol—Headache—Valsartan—coronary artery disease	0.000109	0.000312	CcSEcCtD
Zuclopenthixol—Diarrhoea—Telmisartan—coronary artery disease	0.000109	0.000311	CcSEcCtD
Zuclopenthixol—Headache—Olmesartan—coronary artery disease	0.000109	0.00031	CcSEcCtD
Zuclopenthixol—Paraesthesia—Ramipril—coronary artery disease	0.000109	0.00031	CcSEcCtD
Zuclopenthixol—Thioridazine—HTR2A—coronary artery disease	0.000108	0.0206	CrCbGaD
Zuclopenthixol—Shock—Lisinopril—coronary artery disease	0.000108	0.000308	CcSEcCtD
Zuclopenthixol—Asthenia—Perindopril—coronary artery disease	0.000108	0.000308	CcSEcCtD
Zuclopenthixol—Dyspnoea—Ramipril—coronary artery disease	0.000108	0.000308	CcSEcCtD
Zuclopenthixol—Vomiting—Niacin—coronary artery disease	0.000108	0.000307	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000108	0.000307	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Furosemide—coronary artery disease	0.000108	0.000307	CcSEcCtD
Zuclopenthixol—Somnolence—Ramipril—coronary artery disease	0.000108	0.000307	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Lisinopril—coronary artery disease	0.000107	0.000306	CcSEcCtD
Zuclopenthixol—Dizziness—Trandolapril—coronary artery disease	0.000107	0.000306	CcSEcCtD
Zuclopenthixol—Tachycardia—Lisinopril—coronary artery disease	0.000107	0.000305	CcSEcCtD
Zuclopenthixol—Insomnia—Timolol—coronary artery disease	0.000107	0.000305	CcSEcCtD
Zuclopenthixol—Rash—Niacin—coronary artery disease	0.000107	0.000305	CcSEcCtD
Zuclopenthixol—Dermatitis—Niacin—coronary artery disease	0.000107	0.000305	CcSEcCtD
Zuclopenthixol—Dizziness—Enalapril—coronary artery disease	0.000107	0.000305	CcSEcCtD
Zuclopenthixol—Skin disorder—Lisinopril—coronary artery disease	0.000107	0.000304	CcSEcCtD
Zuclopenthixol—Dyspepsia—Ramipril—coronary artery disease	0.000106	0.000304	CcSEcCtD
Zuclopenthixol—Pruritus—Perindopril—coronary artery disease	0.000106	0.000303	CcSEcCtD
Zuclopenthixol—Headache—Niacin—coronary artery disease	0.000106	0.000303	CcSEcCtD
Zuclopenthixol—Paraesthesia—Timolol—coronary artery disease	0.000106	0.000303	CcSEcCtD
Zuclopenthixol—Vomiting—Pravastatin—coronary artery disease	0.000106	0.000303	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Lisinopril—coronary artery disease	0.000106	0.000302	CcSEcCtD
Zuclopenthixol—Diarrhoea—Captopril—coronary artery disease	0.000106	0.000302	CcSEcCtD
Zuclopenthixol—Dyspnoea—Timolol—coronary artery disease	0.000105	0.000301	CcSEcCtD
Zuclopenthixol—Dizziness—Telmisartan—coronary artery disease	0.000105	0.0003	CcSEcCtD
Zuclopenthixol—Rash—Pravastatin—coronary artery disease	0.000105	0.0003	CcSEcCtD
Zuclopenthixol—Dermatitis—Pravastatin—coronary artery disease	0.000105	0.0003	CcSEcCtD
Zuclopenthixol—Decreased appetite—Ramipril—coronary artery disease	0.000105	0.0003	CcSEcCtD
Zuclopenthixol—Somnolence—Timolol—coronary artery disease	0.000105	0.0003	CcSEcCtD
Zuclopenthixol—Asthenia—Furosemide—coronary artery disease	0.000105	0.000299	CcSEcCtD
Zuclopenthixol—Headache—Pravastatin—coronary artery disease	0.000105	0.000298	CcSEcCtD
Zuclopenthixol—Anorexia—Lisinopril—coronary artery disease	0.000105	0.000298	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000104	0.000298	CcSEcCtD
Zuclopenthixol—Fatigue—Ramipril—coronary artery disease	0.000104	0.000297	CcSEcCtD
Zuclopenthixol—Dyspepsia—Timolol—coronary artery disease	0.000104	0.000297	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Losartan—coronary artery disease	0.000104	0.000296	CcSEcCtD
Zuclopenthixol—Nausea—Valsartan—coronary artery disease	0.000104	0.000295	CcSEcCtD
Zuclopenthixol—Pruritus—Furosemide—coronary artery disease	0.000103	0.000295	CcSEcCtD
Zuclopenthixol—Constipation—Ramipril—coronary artery disease	0.000103	0.000295	CcSEcCtD
Zuclopenthixol—Clozapine—CYP2C19—coronary artery disease	0.000103	0.0197	CrCbGaD
Zuclopenthixol—Nausea—Olmesartan—coronary artery disease	0.000103	0.000294	CcSEcCtD
Zuclopenthixol—Vomiting—Trandolapril—coronary artery disease	0.000103	0.000294	CcSEcCtD
Zuclopenthixol—Diarrhoea—Perindopril—coronary artery disease	0.000103	0.000293	CcSEcCtD
Zuclopenthixol—Decreased appetite—Timolol—coronary artery disease	0.000103	0.000293	CcSEcCtD
Zuclopenthixol—Vomiting—Enalapril—coronary artery disease	0.000103	0.000293	CcSEcCtD
Zuclopenthixol—Hypotension—Lisinopril—coronary artery disease	0.000102	0.000292	CcSEcCtD
Zuclopenthixol—Dizziness—Captopril—coronary artery disease	0.000102	0.000292	CcSEcCtD
Zuclopenthixol—Rash—Trandolapril—coronary artery disease	0.000102	0.000292	CcSEcCtD
Zuclopenthixol—Dermatitis—Trandolapril—coronary artery disease	0.000102	0.000291	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Timolol—coronary artery disease	0.000102	0.000291	CcSEcCtD
Zuclopenthixol—Fatigue—Timolol—coronary artery disease	0.000102	0.000291	CcSEcCtD
Zuclopenthixol—Rash—Enalapril—coronary artery disease	0.000102	0.00029	CcSEcCtD
Zuclopenthixol—Dermatitis—Enalapril—coronary artery disease	0.000102	0.00029	CcSEcCtD
Zuclopenthixol—Headache—Trandolapril—coronary artery disease	0.000102	0.00029	CcSEcCtD
Zuclopenthixol—Vomiting—Telmisartan—coronary artery disease	0.000101	0.000289	CcSEcCtD
Zuclopenthixol—Asthenia—Losartan—coronary artery disease	0.000101	0.000289	CcSEcCtD
Zuclopenthixol—Headache—Enalapril—coronary artery disease	0.000101	0.000289	CcSEcCtD
Zuclopenthixol—Pain—Timolol—coronary artery disease	0.000101	0.000288	CcSEcCtD
Zuclopenthixol—Thioproperazine—ALB—coronary artery disease	0.000101	0.0193	CrCbGaD
Zuclopenthixol—Nausea—Niacin—coronary artery disease	0.000101	0.000287	CcSEcCtD
Zuclopenthixol—Rash—Telmisartan—coronary artery disease	0.0001	0.000286	CcSEcCtD
Zuclopenthixol—Dermatitis—Telmisartan—coronary artery disease	0.0001	0.000286	CcSEcCtD
Zuclopenthixol—Trifluoperazine—HTR2A—coronary artery disease	0.0001	0.0191	CrCbGaD
Zuclopenthixol—Diarrhoea—Furosemide—coronary artery disease	0.0001	0.000285	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	9.99e-05	0.000285	CcSEcCtD
Zuclopenthixol—Pruritus—Losartan—coronary artery disease	9.98e-05	0.000285	CcSEcCtD
Zuclopenthixol—Headache—Telmisartan—coronary artery disease	9.98e-05	0.000285	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Ramipril—coronary artery disease	9.96e-05	0.000284	CcSEcCtD
Zuclopenthixol—Loxapine—HTR2A—coronary artery disease	9.95e-05	0.019	CrCbGaD
Zuclopenthixol—Dizziness—Perindopril—coronary artery disease	9.94e-05	0.000284	CcSEcCtD
Zuclopenthixol—Thiothixene—ALB—coronary artery disease	9.92e-05	0.019	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—coronary artery disease	9.92e-05	0.019	CrCbGaD
Zuclopenthixol—Insomnia—Lisinopril—coronary artery disease	9.92e-05	0.000283	CcSEcCtD
Zuclopenthixol—Nausea—Pravastatin—coronary artery disease	9.92e-05	0.000283	CcSEcCtD
Zuclopenthixol—Perphenazine—HTR2A—coronary artery disease	9.91e-05	0.0189	CrCbGaD
Zuclopenthixol—Gastrointestinal pain—Ramipril—coronary artery disease	9.89e-05	0.000282	CcSEcCtD
Zuclopenthixol—Paraesthesia—Lisinopril—coronary artery disease	9.85e-05	0.000281	CcSEcCtD
Zuclopenthixol—Vomiting—Captopril—coronary artery disease	9.85e-05	0.000281	CcSEcCtD
Zuclopenthixol—Dyspnoea—Lisinopril—coronary artery disease	9.78e-05	0.000279	CcSEcCtD
Zuclopenthixol—Rash—Captopril—coronary artery disease	9.76e-05	0.000279	CcSEcCtD
Zuclopenthixol—Dermatitis—Captopril—coronary artery disease	9.75e-05	0.000278	CcSEcCtD
Zuclopenthixol—Somnolence—Lisinopril—coronary artery disease	9.75e-05	0.000278	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Timolol—coronary artery disease	9.74e-05	0.000278	CcSEcCtD
Zuclopenthixol—Quetiapine—HTR2A—coronary artery disease	9.72e-05	0.0186	CrCbGaD
Zuclopenthixol—Headache—Captopril—coronary artery disease	9.7e-05	0.000277	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Timolol—coronary artery disease	9.67e-05	0.000276	CcSEcCtD
Zuclopenthixol—Dizziness—Furosemide—coronary artery disease	9.67e-05	0.000276	CcSEcCtD
Zuclopenthixol—Dyspepsia—Lisinopril—coronary artery disease	9.65e-05	0.000275	CcSEcCtD
Zuclopenthixol—Diarrhoea—Losartan—coronary artery disease	9.65e-05	0.000275	CcSEcCtD
Zuclopenthixol—Nausea—Trandolapril—coronary artery disease	9.63e-05	0.000275	CcSEcCtD
Zuclopenthixol—Nausea—Enalapril—coronary artery disease	9.59e-05	0.000274	CcSEcCtD
Zuclopenthixol—Vomiting—Perindopril—coronary artery disease	9.56e-05	0.000273	CcSEcCtD
Zuclopenthixol—Abdominal pain—Ramipril—coronary artery disease	9.56e-05	0.000273	CcSEcCtD
Zuclopenthixol—Body temperature increased—Ramipril—coronary artery disease	9.56e-05	0.000273	CcSEcCtD
Zuclopenthixol—Decreased appetite—Lisinopril—coronary artery disease	9.53e-05	0.000272	CcSEcCtD
Zuclopenthixol—Rash—Perindopril—coronary artery disease	9.48e-05	0.00027	CcSEcCtD
Zuclopenthixol—Dermatitis—Perindopril—coronary artery disease	9.47e-05	0.00027	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Lisinopril—coronary artery disease	9.47e-05	0.00027	CcSEcCtD
Zuclopenthixol—Nausea—Telmisartan—coronary artery disease	9.46e-05	0.00027	CcSEcCtD
Zuclopenthixol—Fatigue—Lisinopril—coronary artery disease	9.45e-05	0.00027	CcSEcCtD
Zuclopenthixol—Headache—Perindopril—coronary artery disease	9.42e-05	0.000269	CcSEcCtD
Zuclopenthixol—Constipation—Lisinopril—coronary artery disease	9.38e-05	0.000268	CcSEcCtD
Zuclopenthixol—Pain—Lisinopril—coronary artery disease	9.38e-05	0.000268	CcSEcCtD
Zuclopenthixol—Body temperature increased—Timolol—coronary artery disease	9.35e-05	0.000267	CcSEcCtD
Zuclopenthixol—Abdominal pain—Timolol—coronary artery disease	9.35e-05	0.000267	CcSEcCtD
Zuclopenthixol—Dizziness—Losartan—coronary artery disease	9.33e-05	0.000266	CcSEcCtD
Zuclopenthixol—Vomiting—Furosemide—coronary artery disease	9.29e-05	0.000265	CcSEcCtD
Zuclopenthixol—Rash—Furosemide—coronary artery disease	9.22e-05	0.000263	CcSEcCtD
Zuclopenthixol—Dermatitis—Furosemide—coronary artery disease	9.21e-05	0.000263	CcSEcCtD
Zuclopenthixol—Nausea—Captopril—coronary artery disease	9.2e-05	0.000262	CcSEcCtD
Zuclopenthixol—Headache—Furosemide—coronary artery disease	9.16e-05	0.000261	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Lisinopril—coronary artery disease	9.04e-05	0.000258	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Lisinopril—coronary artery disease	8.97e-05	0.000256	CcSEcCtD
Zuclopenthixol—Vomiting—Losartan—coronary artery disease	8.97e-05	0.000256	CcSEcCtD
Zuclopenthixol—Nausea—Perindopril—coronary artery disease	8.93e-05	0.000255	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Ramipril—coronary artery disease	8.91e-05	0.000254	CcSEcCtD
Zuclopenthixol—Rash—Losartan—coronary artery disease	8.89e-05	0.000254	CcSEcCtD
Zuclopenthixol—Dermatitis—Losartan—coronary artery disease	8.88e-05	0.000253	CcSEcCtD
Zuclopenthixol—Headache—Losartan—coronary artery disease	8.83e-05	0.000252	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Timolol—coronary artery disease	8.71e-05	0.000248	CcSEcCtD
Zuclopenthixol—Nausea—Furosemide—coronary artery disease	8.68e-05	0.000248	CcSEcCtD
Zuclopenthixol—Asthenia—Ramipril—coronary artery disease	8.68e-05	0.000247	CcSEcCtD
Zuclopenthixol—Abdominal pain—Lisinopril—coronary artery disease	8.67e-05	0.000247	CcSEcCtD
Zuclopenthixol—Body temperature increased—Lisinopril—coronary artery disease	8.67e-05	0.000247	CcSEcCtD
Zuclopenthixol—Pruritus—Ramipril—coronary artery disease	8.56e-05	0.000244	CcSEcCtD
Zuclopenthixol—Asthenia—Timolol—coronary artery disease	8.48e-05	0.000242	CcSEcCtD
Zuclopenthixol—Nausea—Losartan—coronary artery disease	8.38e-05	0.000239	CcSEcCtD
Zuclopenthixol—Pruritus—Timolol—coronary artery disease	8.36e-05	0.000239	CcSEcCtD
Zuclopenthixol—Clozapine—HTR2A—coronary artery disease	8.36e-05	0.016	CrCbGaD
Zuclopenthixol—Diarrhoea—Ramipril—coronary artery disease	8.27e-05	0.000236	CcSEcCtD
Zuclopenthixol—Diarrhoea—Timolol—coronary artery disease	8.09e-05	0.000231	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Lisinopril—coronary artery disease	8.08e-05	0.00023	CcSEcCtD
Zuclopenthixol—Dizziness—Ramipril—coronary artery disease	8e-05	0.000228	CcSEcCtD
Zuclopenthixol—Asthenia—Lisinopril—coronary artery disease	7.87e-05	0.000224	CcSEcCtD
Zuclopenthixol—Chlorpromazine—HTR2A—coronary artery disease	7.86e-05	0.015	CrCbGaD
Zuclopenthixol—Dizziness—Timolol—coronary artery disease	7.82e-05	0.000223	CcSEcCtD
Zuclopenthixol—Pruritus—Lisinopril—coronary artery disease	7.76e-05	0.000221	CcSEcCtD
Zuclopenthixol—Vomiting—Ramipril—coronary artery disease	7.69e-05	0.000219	CcSEcCtD
Zuclopenthixol—Rash—Ramipril—coronary artery disease	7.62e-05	0.000217	CcSEcCtD
Zuclopenthixol—Dermatitis—Ramipril—coronary artery disease	7.62e-05	0.000217	CcSEcCtD
Zuclopenthixol—Headache—Ramipril—coronary artery disease	7.58e-05	0.000216	CcSEcCtD
Zuclopenthixol—Vomiting—Timolol—coronary artery disease	7.52e-05	0.000214	CcSEcCtD
Zuclopenthixol—Diarrhoea—Lisinopril—coronary artery disease	7.5e-05	0.000214	CcSEcCtD
Zuclopenthixol—Rash—Timolol—coronary artery disease	7.45e-05	0.000213	CcSEcCtD
Zuclopenthixol—Dermatitis—Timolol—coronary artery disease	7.45e-05	0.000212	CcSEcCtD
Zuclopenthixol—Headache—Timolol—coronary artery disease	7.41e-05	0.000211	CcSEcCtD
Zuclopenthixol—Dizziness—Lisinopril—coronary artery disease	7.25e-05	0.000207	CcSEcCtD
Zuclopenthixol—Nausea—Ramipril—coronary artery disease	7.18e-05	0.000205	CcSEcCtD
Zuclopenthixol—Nausea—Timolol—coronary artery disease	7.02e-05	0.0002	CcSEcCtD
Zuclopenthixol—Vomiting—Lisinopril—coronary artery disease	6.97e-05	0.000199	CcSEcCtD
Zuclopenthixol—Rash—Lisinopril—coronary artery disease	6.91e-05	0.000197	CcSEcCtD
Zuclopenthixol—Dermatitis—Lisinopril—coronary artery disease	6.91e-05	0.000197	CcSEcCtD
Zuclopenthixol—Headache—Lisinopril—coronary artery disease	6.87e-05	0.000196	CcSEcCtD
Zuclopenthixol—Nausea—Lisinopril—coronary artery disease	6.51e-05	0.000186	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ALB—coronary artery disease	5.38e-05	0.0103	CrCbGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AKT1—coronary artery disease	6.2e-06	3.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—coronary artery disease	6.2e-06	3.2e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	6.2e-06	3.2e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—coronary artery disease	6.18e-06	3.19e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOE—coronary artery disease	6.18e-06	3.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	6.18e-06	3.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGT—coronary artery disease	6.18e-06	3.19e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—coronary artery disease	6.17e-06	3.19e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOE—coronary artery disease	6.17e-06	3.19e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—KDR—coronary artery disease	6.15e-06	3.18e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CASP3—coronary artery disease	6.15e-06	3.18e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK14—coronary artery disease	6.11e-06	3.16e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOA1—coronary artery disease	6.11e-06	3.16e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—coronary artery disease	6.11e-06	3.15e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOA1—coronary artery disease	6.1e-06	3.15e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MAPK1—coronary artery disease	6.08e-06	3.14e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—JAK2—coronary artery disease	6.06e-06	3.13e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—KDR—coronary artery disease	6.05e-06	3.13e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—coronary artery disease	6.05e-06	3.13e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOE—coronary artery disease	6.05e-06	3.13e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	6.05e-06	3.12e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—KDR—coronary artery disease	6.04e-06	3.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—C3—coronary artery disease	6.04e-06	3.12e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	6.01e-06	3.11e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK14—coronary artery disease	6e-06	3.1e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ESR1—coronary artery disease	6e-06	3.1e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCND1—coronary artery disease	5.98e-06	3.09e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	5.98e-06	3.09e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—PIK3CA—coronary artery disease	5.94e-06	3.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—KDR—coronary artery disease	5.93e-06	3.06e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FN1—coronary artery disease	5.92e-06	3.06e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—F2—coronary artery disease	5.92e-06	3.06e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ESR1—coronary artery disease	5.9e-06	3.05e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6ST—coronary artery disease	5.9e-06	3.05e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	5.89e-06	3.04e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ESR1—coronary artery disease	5.89e-06	3.04e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARG—coronary artery disease	5.86e-06	3.03e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	5.85e-06	3.02e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FN1—coronary artery disease	5.83e-06	3.01e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—F2—coronary artery disease	5.83e-06	3.01e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—F2—coronary artery disease	5.81e-06	3e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FN1—coronary artery disease	5.81e-06	3e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—coronary artery disease	5.81e-06	3e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	5.8e-06	3e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTP1—coronary artery disease	5.79e-06	2.99e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6ST—coronary artery disease	5.79e-06	2.99e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	5.78e-06	2.98e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—coronary artery disease	5.78e-06	2.98e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	5.76e-06	2.98e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	5.76e-06	2.98e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	5.75e-06	2.97e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.74e-06	2.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGT—coronary artery disease	5.74e-06	2.96e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HMOX1—coronary artery disease	5.71e-06	2.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—AKT1—coronary artery disease	5.71e-06	2.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—F2—coronary artery disease	5.71e-06	2.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FN1—coronary artery disease	5.71e-06	2.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	5.68e-06	2.94e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—KIT—coronary artery disease	5.67e-06	2.93e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAT—coronary artery disease	5.64e-06	2.91e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	5.64e-06	2.91e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AKT1—coronary artery disease	5.63e-06	2.91e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—coronary artery disease	5.62e-06	2.9e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—coronary artery disease	5.62e-06	2.9e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—KIT—coronary artery disease	5.58e-06	2.88e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—KIT—coronary artery disease	5.56e-06	2.88e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	5.56e-06	2.87e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—coronary artery disease	5.53e-06	2.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—KDR—coronary artery disease	5.51e-06	2.85e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOB—coronary artery disease	5.47e-06	2.83e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	5.47e-06	2.83e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—KIT—coronary artery disease	5.46e-06	2.82e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GSK3B—coronary artery disease	5.44e-06	2.81e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—coronary artery disease	5.39e-06	2.79e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CREB1—coronary artery disease	5.39e-06	2.79e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	5.37e-06	2.77e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	5.35e-06	2.76e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GSK3B—coronary artery disease	5.34e-06	2.76e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AKT1—coronary artery disease	5.34e-06	2.76e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.32e-06	2.75e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—coronary artery disease	5.31e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CREB1—coronary artery disease	5.31e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—F2—coronary artery disease	5.3e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FN1—coronary artery disease	5.3e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—coronary artery disease	5.3e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CREB1—coronary artery disease	5.3e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CASP3—coronary artery disease	5.29e-06	2.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	5.28e-06	2.73e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—coronary artery disease	5.28e-06	2.73e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PIK3CA—coronary artery disease	5.28e-06	2.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—coronary artery disease	5.27e-06	2.72e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6R—coronary artery disease	5.26e-06	2.72e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—coronary artery disease	5.26e-06	2.72e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	5.24e-06	2.71e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	5.24e-06	2.71e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPL—coronary artery disease	5.23e-06	2.7e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VEGFA—coronary artery disease	5.22e-06	2.69e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—coronary artery disease	5.2e-06	2.69e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	5.2e-06	2.69e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—coronary artery disease	5.19e-06	2.68e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—coronary artery disease	5.19e-06	2.68e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—coronary artery disease	5.18e-06	2.68e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6R—coronary artery disease	5.18e-06	2.68e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6R—coronary artery disease	5.17e-06	2.67e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	5.16e-06	2.67e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCND1—coronary artery disease	5.15e-06	2.66e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—coronary artery disease	5.11e-06	2.64e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX1—coronary artery disease	5.1e-06	2.63e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—coronary artery disease	5.09e-06	2.63e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	5.09e-06	2.63e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	5.08e-06	2.63e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—KIT—coronary artery disease	5.07e-06	2.62e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	5.07e-06	2.62e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	5.07e-06	2.62e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—coronary artery disease	5.04e-06	2.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	5e-06	2.58e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—coronary artery disease	5e-06	2.58e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	4.98e-06	2.57e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CD36—coronary artery disease	4.97e-06	2.57e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.94e-06	2.55e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	4.93e-06	2.55e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.9e-06	2.53e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	4.87e-06	2.52e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.86e-06	2.51e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AKT1—coronary artery disease	4.85e-06	2.51e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	4.85e-06	2.51e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.85e-06	2.5e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	4.84e-06	2.5e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	4.83e-06	2.5e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—coronary artery disease	4.83e-06	2.5e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—coronary artery disease	4.79e-06	2.47e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FGF2—coronary artery disease	4.77e-06	2.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.75e-06	2.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	4.75e-06	2.45e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	4.73e-06	2.44e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	4.71e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.71e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—coronary artery disease	4.7e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK1—coronary artery disease	4.69e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FGF2—coronary artery disease	4.69e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FGF2—coronary artery disease	4.68e-06	2.42e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—coronary artery disease	4.67e-06	2.41e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	4.65e-06	2.4e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—coronary artery disease	4.63e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	4.62e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—coronary artery disease	4.62e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—coronary artery disease	4.61e-06	2.38e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	4.6e-06	2.37e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—JAK2—coronary artery disease	4.57e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	4.53e-06	2.34e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—JAK2—coronary artery disease	4.5e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—JAK2—coronary artery disease	4.49e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VEGFA—coronary artery disease	4.49e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	4.48e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGT—coronary artery disease	4.47e-06	2.31e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.42e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	4.41e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	4.41e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	4.41e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	4.4e-06	2.27e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—coronary artery disease	4.38e-06	2.26e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOA1—coronary artery disease	4.33e-06	2.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	4.32e-06	2.23e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AKT1—coronary artery disease	4.31e-06	2.23e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	4.27e-06	2.21e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	4.21e-06	2.18e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—coronary artery disease	4.17e-06	2.16e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—coronary artery disease	4.12e-06	2.13e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	4.11e-06	2.12e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—coronary artery disease	4.1e-06	2.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	4.09e-06	2.11e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	4.07e-06	2.1e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK1—coronary artery disease	4.04e-06	2.09e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	4.03e-06	2.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	4.02e-06	2.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	4.01e-06	2.07e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CASP3—coronary artery disease	3.99e-06	2.06e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—coronary artery disease	3.97e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	3.97e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	3.96e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CASP3—coronary artery disease	3.93e-06	2.03e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CASP3—coronary artery disease	3.92e-06	2.03e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—coronary artery disease	3.9e-06	2.02e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—coronary artery disease	3.9e-06	2.01e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCND1—coronary artery disease	3.89e-06	2.01e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	3.88e-06	2.01e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	3.85e-06	1.99e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCND1—coronary artery disease	3.83e-06	1.98e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	3.82e-06	1.98e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCND1—coronary artery disease	3.82e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARG—coronary artery disease	3.82e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—coronary artery disease	3.77e-06	1.95e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—coronary artery disease	3.76e-06	1.94e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	3.75e-06	1.94e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	3.74e-06	1.93e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—coronary artery disease	3.71e-06	1.92e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—coronary artery disease	3.71e-06	1.91e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AKT1—coronary artery disease	3.66e-06	1.89e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	3.64e-06	1.88e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	3.61e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—coronary artery disease	3.61e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	3.6e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AKT1—coronary artery disease	3.59e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	3.58e-06	1.85e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	3.55e-06	1.84e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	3.53e-06	1.82e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	3.51e-06	1.81e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	3.48e-06	1.8e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—coronary artery disease	3.43e-06	1.77e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VEGFA—coronary artery disease	3.39e-06	1.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	3.38e-06	1.75e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	3.34e-06	1.72e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VEGFA—coronary artery disease	3.33e-06	1.72e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AKT1—coronary artery disease	3.33e-06	1.72e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—coronary artery disease	3.28e-06	1.7e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	3.28e-06	1.69e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	3.27e-06	1.69e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—coronary artery disease	3.11e-06	1.61e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—coronary artery disease	3.1e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	3.06e-06	1.58e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—coronary artery disease	3.05e-06	1.58e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK1—coronary artery disease	3.05e-06	1.58e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	3.03e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	3e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—coronary artery disease	3e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	3e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK1—coronary artery disease	3e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	2.94e-06	1.52e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AKT1—coronary artery disease	2.86e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CA—coronary artery disease	2.83e-06	1.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	2.78e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	2.73e-06	1.41e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	2.65e-06	1.37e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	2.6e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	2.6e-06	1.34e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	2.55e-06	1.32e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	2.37e-06	1.22e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—coronary artery disease	2.34e-06	1.21e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AKT1—coronary artery disease	2.32e-06	1.2e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—coronary artery disease	2.31e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—coronary artery disease	2.3e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—coronary artery disease	2.26e-06	1.17e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT1—coronary artery disease	2.16e-06	1.12e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT1—coronary artery disease	2.13e-06	1.1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT1—coronary artery disease	2.12e-06	1.1e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—coronary artery disease	2.1e-06	1.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	2.08e-06	1.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.94e-06	1e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.85e-06	9.54e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AKT1—coronary artery disease	1.51e-06	7.8e-06	CbGpPWpGaD
